Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy Edition

published 1 month ago by Dr Neil Love

Featuring an interview with Dr Courtney D DiNardo on recent data on the management of acute myeloid leukemia not eligible for intensive induction therapy, including the following topics: Management of Acute Myeloid Leukemia in Patients Not Eligible for Intensive Induction Therapy — Courtney D DiNardo, MD, MSCE (00:00) Case: A woman in her mid-70s with AML and diploid cytogenetics with mutations in NPM1, IDH1 and FLT3-TKD who receives venetoclax with a hypomethylating agent (21:20) Case: A man in his late 60s with AML with del(5q), del(7q) and mutations in RUNX1 and SRSF2 (28:57) Case: A woman in her late 60s with relapsed/refractory AML with intermediate-risk cytogenetics (35:22) CME information and select publications

more episodes from Research To Practice | Oncology Videos